SGLT1/2 Inhibitor Cut Stroke, Heart Attack Risk in Diabetic Kidney Disease

(MedPage Today)-SGLTLIFLOZIN (INPEFA) reduce the risk of myocardial infarction (MI) and stroke in patients at risk with type 2 diabetes (T2D), and chronic kidney disease (CKD) factors, pre-determined. ..